I don't know about you guys but I am excited:
The abstract, titled ‘CF33-hNIS, a novel oncolytic virus for the treatment of
cholangiocarcinoma and biliary tract malignancies,’ concludes that CF33-hNIS
monotherapy may be an effective and safe treatment option for GI malignancies,
including cholangiocarcinoma, a rare disease with an unmet medical need.
Spozzie
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-19
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.002(3.64%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.9¢ | 5.5¢ | $1.176M | 20.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1135235 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 477220 | 6 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |